Clinical Trial Update: Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated whether concomitant treatment with omeprazole, pantoprazole, or famotidine alters clopidogrel’s platelet inhibitory effect in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Gastrointestinal Hemorrhage

Drugs mentioned

• Pepcid (famotidine) (famotidine)
• Plavix (clopidogrel) (clopidogrel)
• Prilosec (omeprazole) (omeprazole)
• Protonix (pantoprazole) (pantoprazole)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Coronary Heart Disease, GI Bleeding | Phase 4 | Status: COMPLETED